Dr. Robert Wong, MD
Claim this profileAustin Retina Associates
Studies Retinal Disease
Studies Diabetic Retinopathy
5 reported clinical trials
10 drugs studied
Affiliated Hospitals
Clinical Trials Robert Wong, MD is currently running
4D-150
for Age-Related Macular Degeneration
Phase 1/2 dose-escalation and randomized, controlled, masked expansion trial in adults with wet AMD undergoing active anti-VEGF treatment
Recruiting1 award Phase 1 & 23 criteria
Fenofibrate
for Diabetic Retinopathy
This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 6 years of follow-up in eyes with mild to moderately severe non-proliferative DR (NPDR) and no CI-DME at baseline. In addition to evaluating efficacy, this study aims to evaluate the feasibility of a model for ophthalmologists to prescribe or collaborate with a primary care provider such as an internist/endocrinologist to prescribe and monitor the drug safely. If this study demonstrates that fenofibrate is effective for reducing the onset of proliferative diabetic retinopathy (PDR) or and the results are adopted by the community of retina specialists, a new strategy to prevent vision threatening complications of diabetes could be widely adopted. Widespread use of an oral agent effective at reducing worsening of DR would decrease the numbers of patients who undergo more invasive and much more expensive treatment for DR and who are consequently at risk for side effects that adversely affect visual function. This study will also assess the relationship of glycemic variability, as measured by continuous glucose monitoring with DR outcomes. Ancillary studies will characterize functional and structural outcomes in this cohort.
Recruiting1 award Phase 35 criteria
More about Robert Wong, MD
Clinical Trial Related3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Robert Wong, MD has experience with
- Fenofibrate
- Placebo
- Oncoguard™ Liver Test
- Standard Of Care CT/MRI Imaging
- Study CT/MRI Imaging
- Faricimab
Breakdown of trials Robert Wong, MD has run
Diabetic Retinopathy
Age-Related Macular Degeneration
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Robert Wong, MD specialize in?
Robert Wong, MD focuses on Retinal Disease and Diabetic Retinopathy. In particular, much of their work with Retinal Disease has involved treating patients, or patients who are undergoing treatment.
Is Robert Wong, MD currently recruiting for clinical trials?
Yes, Robert Wong, MD is currently recruiting for 3 clinical trials in Austin Texas. If you're interested in participating, you should apply.
Are there any treatments that Robert Wong, MD has studied deeply?
Yes, Robert Wong, MD has studied treatments such as Fenofibrate, Placebo, Oncoguard™ Liver Test.
What is the best way to schedule an appointment with Robert Wong, MD?
Apply for one of the trials that Robert Wong, MD is conducting.
What is the office address of Robert Wong, MD?
The office of Robert Wong, MD is located at: Austin Retina Associates, Austin, Texas 78705 United States. This is the address for their practice at the Austin Retina Associates.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.